The Claim
The PD-1/PD-L1 pathway is activated in Hashimoto thyroiditis, with PD-L1 expressed on thyroid follicular cells and intrathyroidal lymphocytes, functioning as a feedback mechanism to limit immune-mediated destruction of thyroid tissue.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In Hashimoto thyroiditis, PD-L1 protein is present on thyroid cells and nearby immune cells, and this interaction reduces immune system activity against the thyroid.
See the scientific wording
The PD-1/PD-L1 pathway is engaged in Hashimoto thyroiditis, with PD-L1 expressed on both thyroid follicular cells and intrathyroidal lymphocytes, potentially serving as a feedback mechanism to limit immune-mediated destruction.
Thyroid cells exposed to chronic inflammation produce a protein called PD-L1 on their surface, which binds to a receptor on immune cells that are attacking the thyroid. This binding turns off those immune cells, stopping them from destroying thyroid tissue. At the same time, a special type of immune cell that suppresses inflammation also becomes active and uses the same PD-L1 signal to calm down other immune cells. Together, these actions slow down the destruction of the thyroid, making the disease last longer instead of causing sudden damage.
What the research says
1 studyScientists found that in people with Hashimoto’s thyroiditis, the thyroid cells and nearby immune cells make a protein called PD-L1 that acts like a 'stop signal' to calm down the immune attack — just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.